These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9133540)

  • 1. Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    Diabetes; 1997 May; 46(5):750-7. PubMed ID: 9133540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 1996 Feb; 178(2):176-81. PubMed ID: 8683386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
    Reddy S; Young M; Poole CA; Ross JM
    Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant role for Fas in the pathogenesis of autoimmune diabetes.
    Su X; Hu Q; Kristan JM; Costa C; Shen Y; Gero D; Matis LA; Wang Y
    J Immunol; 2000 Mar; 164(5):2523-32. PubMed ID: 10679090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes.
    Augstein P; Elefanty AG; Allison J; Harrison LC
    Diabetologia; 1998 Nov; 41(11):1381-8. PubMed ID: 9833948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
    Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG
    J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent sensitivity to streptozotocin of pancreatic islets isolated from female NOD mice.
    Reddy S; Sandler S
    Autoimmunity; 1995; 22(2):121-6. PubMed ID: 8722582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Fas ligand in the development of insulitis in nonobese diabetic mice.
    Sainio-Pöllänen S; Erkkilä S; Alanko S; Hänninen A; Pöllänen P; Simell O
    Pancreas; 1998 Mar; 16(2):154-9. PubMed ID: 9510138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-cell apoptosis in an accelerated model of autoimmune diabetes.
    Augstein P; Stephens LA; Allison J; Elefanty AG; Ekberg M; Kay TW; Harrison LC
    Mol Med; 1998 Aug; 4(8):495-501. PubMed ID: 9742505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thymus as a site for evaluating the potency of candidate beta cell autoantigens in NOD mice.
    Gerling IC; Atkinson MA; Leiter EH
    J Autoimmun; 1994 Dec; 7(6):851-8. PubMed ID: 7888041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of insulitis and diabetes in B cell-deficient NOD mice.
    Yang M; Charlton B; Gautam AM
    J Autoimmun; 1997 Jun; 10(3):257-60. PubMed ID: 9218752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid receptor expression is altered in pancreatic beta cells of the non-obese diabetic mouse during postnatal development.
    Thompson A; Arany EJ; Hill DJ; Yang K
    Metabolism; 2002 Jun; 51(6):765-8. PubMed ID: 12037732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11-Keto-β-Boswellic Acid Inhibits Lymphocyte (CD3) Infiltration Into Pancreatic Islets of Young None Obese Diabetic (NOD) Mice.
    Shehata AM; Quintanilla-Fend L; Bettio S; Kamyabi-Moghaddam Z; Kohlhofer UA; Scherbaum WA; Ammon HPT
    Horm Metab Res; 2017 Sep; 49(9):693-700. PubMed ID: 28759942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis in the adrenal gland of non-obese diabetic (NOD) mice.
    Breidert M; Böttner A; Möller S; Herberg L; Bornstein S
    Exp Clin Endocrinol Diabetes; 1998; 106(6):478-83. PubMed ID: 10079028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes.
    Gerling IC; Friedman H; Greiner DL; Shultz LD; Leiter EH
    Diabetes; 1994 Mar; 43(3):433-40. PubMed ID: 8314017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse.
    Sreenan S; Pick AJ; Levisetti M; Baldwin AC; Pugh W; Polonsky KS
    Diabetes; 1999 May; 48(5):989-96. PubMed ID: 10331402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice.
    Yang ZD; Chen M; Wu R; McDuffie M; Nadler JL
    Diabetologia; 2002 Sep; 45(9):1307-14. PubMed ID: 12242464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of caspase-3-expressing cells within the pancreas of non-obese diabetic mice during cyclophosphamide-accelerated diabetes.
    Reddy S; Bradley J; Ginn S; Pathipati P; Ross JM
    Histochem Cell Biol; 2003 Jun; 119(6):451-61. PubMed ID: 12802593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus.
    Strandell E; Eizirik DL; Sandler S
    J Clin Invest; 1990 Jun; 85(6):1944-50. PubMed ID: 2189896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.